Shopping Cart
Remove All
Your shopping cart is currently empty
Quavonlimab
😃Good
Catalog No. T81329Cas No. 2254059-25-9
Alias MK-1308, MK1308
Quavonlimab (MK-1308) is a novel human monoclonal antibody designed to selectively target and block the immune checkpoint molecule cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), investigation of quavonlimab in combination with the anti-PD-1 therapy KEYTRUDA (pembrolizumab) has shown encouraging anti-tumor activity along with an acceptable safety profile,making it an interesting compound for the reasearches into advanced non-small cell lung cancer (NSCLC).
Quavonlimab
Quavonlimab
😃Good
Purity: 95%
Catalog No. T81329Alias MK-1308, MK1308Cas No. 2254059-25-9
Quavonlimab (MK-1308) is a novel human monoclonal antibody designed to selectively target and block the immune checkpoint molecule cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), investigation of quavonlimab in combination with the anti-PD-1 therapy KEYTRUDA (pembrolizumab) has shown encouraging anti-tumor activity along with an acceptable safety profile,making it an interesting compound for the reasearches into advanced non-small cell lung cancer (NSCLC).
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $332 | - | In Stock | |
| 5 mg | $996 | - | In Stock | |
| 10 mg | $1,570 | - | In Stock | |
| 25 mg | $2,330 | - | In Stock | |
| 50 mg | $3,130 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:96.7% (SDS-PAGE); 96.9% (SEC-HPLC)
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Quavonlimab (MK-1308) is a novel human monoclonal antibody designed to selectively target and block the immune checkpoint molecule cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), investigation of quavonlimab in combination with the anti-PD-1 therapy KEYTRUDA (pembrolizumab) has shown encouraging anti-tumor activity along with an acceptable safety profile,making it an interesting compound for the reasearches into advanced non-small cell lung cancer (NSCLC). |
| Synonyms | MK-1308, MK1308 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | CTLA-4/CD152 |
| Molecular Weight | 144.22 kDa |
| Cas No. | 2254059-25-9 |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Quavonlimab | purchase Quavonlimab | Quavonlimab cost | order Quavonlimab | Quavonlimab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.